ARWR
Arrowhead Pharmaceuticals Inc
66.10$
-1.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.01 | 0.00 | 0.43 | 0.19 | 1.71 | 0.87 | 1.33 | 2.31 | 2.26 | 0.03 | 6.20 | |
| 0.08 | 1.43 | 1.35 | 0.86 | 0.81 | – | – | – | 0.10 | 0.12 | 0.16 | 0.18 | |
| -0.08 | 0.01 | 0.00 | 0.43 | 0.19 | 1.71 | 0.87 | 1.33 | 2.31 | 2.14 | -0.13 | 6.20 | |
| 0.49 | 0.82 | 0.68 | 0.63 | 0.58 | 0.78 | 1.23 | 1.99 | 2.82 | 3.21 | 4.08 | 4.54 | |
| 0.52 | 0.61 | 0.39 | 0.24 | 0.23 | 0.27 | 0.52 | 0.78 | 1.18 | 0.85 | 0.81 | 0.91 | |
| 1.01 | 1.43 | 1.35 | 0.86 | 0.81 | 1.05 | 1.74 | 2.77 | 4.00 | 4.06 | 4.89 | 5.47 | |
| -1.14 | -1.67 | -1.34 | -0.50 | -0.67 | 0.62 | -0.92 | -1.44 | -1.69 | -1.92 | -5.02 | 0.74 | |
| 13.75 | 12.71 | 4.35 | 5.62 | 12.54 | 70.56 | 91.25 | 0.06 | 0.05 | 0.17 | 0.27 | 0.67 | |
| -1.25 | -1.60 | -1.34 | -0.47 | -0.65 | 0.69 | -0.84 | -1.36 | -1.64 | -1.93 | -5.11 | 0.39 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.03 | -0.02 | 0.16 | |
| -1.25 | -1.60 | -1.34 | -0.47 | -0.65 | 0.69 | -0.84 | -1.36 | -1.67 | -1.92 | -5.00 | -0.01 | |
| -1.06 | -1.63 | -1.25 | -0.44 | -0.61 | 0.67 | -0.87 | -1.28 | -1.59 | -1.65 | -4.69 | 1.23 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.